Serological correlate of protection against norovirus-induced gastroenteritis

Journal of Infectious Diseases

Volumn 202, Issue 8, 2010, Pages 1212-1218

  Reeck, Amanda ^a   Kavanagh, Owen ^a   Estes, Mary K ^a   Opekun, Antone R ^a   Gilger, Mark A ^a   Graham, David Y ^a   Atmar, Robert L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BLOCKING ANTIBODY; BLOOD GROUP ANTIGEN; GLYCAN; POLYSACCHARIDE;

ACUTE GASTROENTERITIS; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ASSAY; BLOOD GROUP; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORRELATION ANALYSIS; GASTROENTERITIS; HOST SUSCEPTIBILITY; HUMAN; HUMAN EXPERIMENT; IMMUNITY; NOROVIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGISTRATION; SAMPLE; SEROLOGY; SERUM; VIRUS INFECTION; VIRUS PARTICLE; VIRUS TYPING; ADOLESCENT; BIOASSAY; BLOOD; CALICIVIRUS INFECTION; CLINICAL TRIAL; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; VIROLOGY; VIRUS SHEDDING;

ADOLESCENT; ADULT; ANTIBODIES, BLOCKING; BIOLOGICAL ASSAY; CALICIVIRIDAE INFECTIONS; GASTROENTERITIS; HUMANS; MIDDLE AGED; NORWALK VIRUS; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS; VIRUS SHEDDING; YOUNG ADULT;

EID: 77957005956     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656364     Document Type: Article

References (33)

1. Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am 2006; 35:275-290.
2. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607-625. (Pubitemid 29493763)
3. Hutson AM, Airaud F, LePendu J, Estes MK, Atmar RL. Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol 2005; 77:116-120. (Pubitemid 41076487)
4. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002; 185:1335-1337.
5. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9:548-553. (Pubitemid 36597100)
6. Jiang X, Wang M, Graham DY, Estes MK. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 1992; 66:6527-6532.
7. Baric RS, Yount B, Lindesmith L, et al. Expression and self-assembly of norwalk virus capsid protein from Venezuelan equine encephalitis virus replicons. J Virol 2002; 76:3023-3030. (Pubitemid 34184887)
8. Green KY, Lew JF, Jiang X, Kapikian AZ, Estes MK. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 1993; 31:2185-2191. (Pubitemid 23210516)
9. White LJ, Ball JM, Hardy ME, Tanaka TN, Kitamoto N, Estes MK. Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol 1996; 70:6589-6597. (Pubitemid 26307363)
10. Hutson AM, Atmar RL, Estes MK. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol 2004; 12:279-287.
11. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol 2010; 8:231-241.
12. Huang P, Farkas T, Zhong W, et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 2005; 79:6714-6722. (Pubitemid 40677302)
13. Tan M, Jiang X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 2005; 13:285-293. (Pubitemid 40779817)
14. Shirato H, Ogawa S, Ito H, et al. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 2008; 82:10756-10767. (Pubitemid 352691181)
15. Black RE, Greenberg HB, Kapikian AZ, Brown KH, Becker S. Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis 1982; 145:483-489.
16. Ryder RW, Singh N, Reeves WC, Kapikian AZ, Greenberg HB, Sack RB. Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J Infect Dis 1985; 151:99-105. (Pubitemid 15192886)
17. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 1977; 297:86-89.
18. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 1990; 161:18-21.
19. LoBue AD, Lindesmith L, Yount B, et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006; 24:5220-5234. (Pubitemid 43818189)
20. Lindesmith LC, Donaldson E, Leon J, et al. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol 2010; 84:1800-1815.
21. Cannon JL, Lindesmith LC, Donaldson EF, Saxe L, Baric RS, Vinje J. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol 2009; 83:5363-5374.
22. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 2002; 76:12335-12343. (Pubitemid 35304332)
23. Atmar RL, Opekun AR, Gilger MA, et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14:1553-1557.
24. Graham DY, Jiang X, Tanaka T, Opekun AR, Madore HP, Estes MK. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis 1994; 170:34-43. (Pubitemid 24186422)
25. Marionneau S, Ruvoen N, Le Moullac-Vaidye B, et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002; 122:1967-1977. (Pubitemid 34651439)
26. Hutson AM, Atmar RL, Marcus DM, Estes MK. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J Virol 2003; 77:405-415.
27. Huflejt ME, Vuskovic M, Vasiliu D, et al. Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges. Mol Immunol 2009; 46:3037-3049.
28. Pichichero ME. Booster vaccinations: can immunologic memory outpace disease pathogenesis? Pediatrics 2009; 124:1633-1641.
29. Stussi G, Huggel K, Lutz HU, Schanz U, Rieben R, Seebach JD. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005; 130:954-963. (Pubitemid 43899736)
30. Choi JM, Hutson AM, Estes MK, Prasad BV. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A 2008; 105:9175-9180.
31. Gray JJ, Cunliffe C, Ball J, Graham DY, Desselberger U, Estes MK. Detection of immunoglobulinM(IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol 1994; 32:3059-3063. (Pubitemid 24364018)
32. Okhuysen PC, Jiang X, Ye L, Johnson PC, Estes MK. Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis 1995; 171:566-569.
33. Baron RC, Greenberg HB, Cukor G, Blacklow NR. Serological responses among teenagers after natural exposure to Norwalk virus. J Infect Dis 1984; 150:531-534. (Pubitemid 14013973)